Comments
Loading...
Mosaic ImmunoEngineering Analyst Ratings and Price Targets | OTC:CPMV | Benzinga
Mosaic ImmunoEngineering Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Mosaic ImmunoEngineering Corp from these most-recent analyst ratings.
Analyst Ratings for Mosaic ImmunoEngineering
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Mosaic ImmunoEngineering (CPMV) stock?
There is no price target for Mosaic ImmunoEngineering
What is the most recent analyst rating for Mosaic ImmunoEngineering (CPMV)?
There is no analyst for Mosaic ImmunoEngineering
When was the last upgrade for Mosaic ImmunoEngineering (CPMV)?
There is no last upgrade for Mosaic ImmunoEngineering
When was the last downgrade for Mosaic ImmunoEngineering (CPMV)?
There is no last downgrade for Mosaic ImmunoEngineering.
When is the next analyst rating going to be posted or updated for Mosaic ImmunoEngineering (CPMV)?
There is no next analyst rating for Mosaic ImmunoEngineering.
Is the Analyst Rating Mosaic ImmunoEngineering (CPMV) correct?
There is no next analyst rating for Mosaic ImmunoEngineering.
Browse analyst ratings and price targets on all stocks.